Inverse targeting of retroviral vectors: Selective gene transfer in a mixed population of hematopoietic and nonhematopoietic cells

Blood

Volumn 91, Issue 5, 1998, Pages 1802-1809

  Fielding, Adele K ^b   Maurice, Marielle ^b   Morling, Frances J ^b   Cosset, François Löic ^b   Russell, Stephen J ^a  

^a MEDICAL RESEARCH COUNCIL   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS VECTOR;

ANIMAL CELL; ARTICLE; CELL POPULATION; CELL SURFACE; GENE TARGETING; GENE THERAPY; GENE TRANSFER; HEMATOPOIETIC CELL; NONHUMAN; PRIORITY JOURNAL; RETROVIRUS; STEM CELL; TARGET CELL; VIRUS INFECTION;

EID: 0032032363     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v91.5.1802.1802_1802_1809     Document Type: Article

References (52)

1. Ward M, Richardson C, Pioli P, Smith L, Podda S, Goff S, Hesdorffer C, Bank A: Transfer and expression of the human multiple drug resistance gene in human CD34+ cells. Blood 84:1408, 1994
2. Begni M, Magni M, Siena S, DiNicola M, Bonnadonna G, Gianni AM: Human peripheral blood hematopoietic progenitors are optimal targets of retroviral-mediated gene transfer. Blood 80:1418, 1992
3. Dick JE, Kamel-Reid S, Murdoch B, Deodnes M: Gene transfer into normal human hematopoietic stem cells using in vitro and in vivo assays. Blood 78:624, 1991
4. Hughes PF, Thacker JD, Hogge D, Sutherland HJ, Thomas TE, Lansdorp PM, Eaves CJ, Humphries RK: Retroviral gene transfer to primitive normal and leukaemic hematopoietic cells using clinically applicable procedures. J Clin Invest 89:1817, 1992
5. Brenner MK, Rill DR, Holladay MS, Heslop HE, Moen RC, Buschle M, Krance RA, Santana VM, Anderson WF, Ihle JN: Gene marking to determine whether autologous marrow infusion restores long-term haemopoiesis in cancer patients. Lancet 342:1134, 1994
6. Deisseroth AB, Zu Z, Claxton D, Hanania EG, Fu S, Ellerson D, Goldberg L, Thomas M, Janicek K, Anderson WF: Genetic marking shows that Ph+ cells present in autologous transplants of chronic myelogenous leukemia (CML) contribute to relapse after autologous bone marrow in CML. Blood 83:3068, 1994
7. Dunbar CE, Cottier-Fox M, O'Shaughnessy JA, Doren S, Carter C, Berenson R, Brown S, Moen R, Greenblatt J, Stewart M, Leitman SF, Wilson WH, Cowan K, Young NS, Nienhuis AW: Retrovirally marked CD34 enriched peripheral blood and bone marrow cells contribute to long term engraftment after autologous transplant. Blood 85:3048, 1995
8. Berardi AC, Wang A, Levine JD, Lopez P, Scadden DT: Functional isolation and characterisation of human hematopoietic stem cells. Science 267:104, 1995
9. Miller DG, Adam MA, Miller AD: Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection. Mol Cell Biol 10:4239, 1990
10. Orlic D, Girard LJ, Jordan CT, Anderson SM, Cline AP, Bodine DM: The level of mRNA encoding the amphotropic retrovirus receptor in mouse and human hematopoietic stem cells is low and correlates with the efficiency of retrovirus transduction. Proc Natl Acad Sci USA 93:11097, 1996
11. Battini JL, Heard JM, Danos O: Receptor choice determinants in the envelope glycoproteins of amphotropic, xenotropic, and polytropic murine leukemia viruses. J Virol 66:1468, 1992
12. Albritton LM, Tseng L, Scadden D, Cunningham JM: Envelope binding domain in the cationic amino acid transporter determines the host range of ecotropic murine retroviruses. J Virol 67:2091, 1993
13. Kavanagh MP, Miller DG, Zhang W, Law W, Kozak SL, Kabat D, Miller AD: Cell surface receptors for gibbon ape leukaemia virus and amphotropic murine retrovirus are inducible sodium dependent phosphate symporters. Proc Natl Acad Sci USA 91:7071, 1994
14. Russell SJ, Hawkins RE, Winter G: Retroviral vectors displaying functional antibody fragments. Nucleic Acids Res 21:1081, 1993
15. Cosset FL, Morling FJ, Takeuchi Y, Weiss RA, Collins MKL, Russell SJ: Retroviral retargeting by envelopes expressing an N-terminal binding domain. J Virol 69:6314, 1995
16. Ager S, Nilson BHK, Morling FJ, Peng KW, Cosset F-L, Russell SJ: Retroviral display of antibody fragments: Interdomain spacing strongly influences vector infectivity. Hum Gene Ther 7:2157, 1996
17. Valsesia-Wittman S, Morling FJ, Nilson BHK, Takeuchi Y, Russell SJ, Cosset F-L: Improvment of retroviral re-targeting by using amino acid spacers between an additional binding domain and the N terminus of Moloney murine leukaemia virus SU. J Virol 70:2059, 1996
18. Nilson BHK, Morling FJ, Cosset FL, Russell SJ: Targeting of retroviral vectors by protease-substrate interactions. Gene Ther 3:280, 1996
19. Ogawa M, Matsuzaki Y, Nishikawa S, Hayashi SI, Kunisada T, Sudo T, Kina T, Nakauchi H, Nishikawa SI: Expression and function of c-kit in hemopoietic progenitor cells. J Exp Med 74:63, 1991
20. Abkowitz JL, Broudy VC, Bennett LG, Zsebo KM, Martin FH: Absence of abnormalities of c-kit or its ligand in two patients with Diamond-Blackfan anaemia. Blood 79:25, 1992
21. Turner AM, Zsebo KM, Martin F, Jacobsen FW, Bennett LG, Broudy VC: Nonhematpoietic cell lines express stem cell factor and display c-kit receptors. Blood 80:374, 1992
22. Flanagan G, Chan DC, Leder P: Transmembrane form of the kit ligand growth factor is determined by alternative splicing and is missing in the Sld mutant. Cell 64:1025, 1991
23. Toksoz D, Zsebo KM, Smith KA, Hu S, Brankow D, Suggs SV, Martin FH, Williams DA: Support of human hematopoiesis in longterm bone marrow cultures by murine stromal cells selectively expressing the membrane-bound and secreted forms of the human homolog of the steel gene product, stem cell factor. Proc Natl Acad Sci USA 89:7350, 1992
24. Lu HS, Clogston CL, Wypych J, Parker VP, Lee TD, Swiderek K, Baltera RF Jr, Patel AC, Chang DC, Brankow DW: Post-translational processing of membrane-associated recombinant human stem cell factor expressed in Chinese hamster ovary cells. Arch Biochem Biophys 298:150, 1992
25. Langley KE, Bennett LG, Wypuch J, Yancik SA, Liu XD, Wesdtcott KR, Chang DG, Smith KA, Zsebo KM: Soluble stem cell factor in human serum. Blood 81:656, 1993
26. Cosset F-L, Takeuchi Y, Battini J-L, Weiss RA, Collins MLK: High titre cells producing recombinant retroviruses resistant to human serum. J Virol 69:7430, 1995
27. Sambrook J, Fritsch EF, Maniatis T: Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY, Cold Spring Harbor Laboratory, 1989
28. Butterfield JH, Weiler D, Dewald G, Gleich GJ: Establishment of an immature mast cell line from a patient with mast cell leukaemia. Leuk Res 12:345, 1988
29. Zhen-Bo H, Weili M, Uphoff CC, Quentmeier H, Drexler HG: c-kit expression in human megakaryoblastic leukaemia cell lines. Blood 83:2133, 1994
30. Cole SR, Aylett GW, Harvey NL, Cambareri AC, Ashman LK: Increased expression of c-kit or its ligand Steel factor is not a common feature of adult acute myeloid leukaemia. Leukemia 10:288, 1996
31. Takeuchi Y, Cosset F-L, Lachmann PJ, Okada H, Weiss R, Collins MLK: Type C retrovirus inactivation by human complemement is determined by both the viral genome and producer cell. J Virol 68:8001, 1994
32. Evans LH, Morrison RP, Malik FG, Portis J, Britt: A neutralizable epitope common to the enevelope glycoproteins of ecotropic, xenotropic and amphotropic murne leukaemia viruses. J Virol 64:6176, 1990
33. Kamps CA, Lin YC, Wong PKY: Oligomerization and transport of the envelope protein of Moloney murine leukemia virus-TB and of ts1, a neurovirulent temperature-sensitive mutant of MoMuLV-TB. Virology 184:685, 1991
34. Fass D, Harrison SC, Kim PS: Retrovirus envelope domain at 1.7 A resolution. Nature Struct Biol 3:465, 1996
35. Lu HS, Chang WC, Mendiaz EA, Mann MB, Langley KE, Hsu YR: Spontaneous dissociation-association of monomers of the humanstem-cell-factor dimer. Biochem J 305:563, 1995
36. Hsu YR, Wu GM, Mendiaz EA, Syed R, Wypych J, Toso R, Mann MB, Boone TC, Nahri LO, Lu HS, Langley KE: The majority of stem cell factor exists as monomer under physiological conditions. Implications for dimerization mediating biological activity. J Biol Chem 272:6406, 1997
37. Kasahara N, Dozy AM, Kan YW: Tissue-specific targeting of retroviral vectors through ligand receptor interactions. Science 226: 1373, 1994
38. Han X, Kasahara N, Kan YW: Ligand directed retroviral targeting of human breast cancer cells. Proc Natl Acad Sci USA 92:9747, 1995
39. Chu THT, Martinez I, Sheay WC, Dornburg R: Cell targeting with retroviral vector particles containing antibody-envelope fusion proteins. Gene Ther 1:292, 1994
40. Chu THT, Dornburg R: Retroviral vector particles displaying the antigen binding site of an antibody enable cell type specific gene transfer. J Virol 69:2659, 1995
41. Somia NV, Zopee M, Verma IM: Generation of targeted retroviral vectors by using single-chain variable fragment: An approach to in vivo gene delivery. Proc Natl Acad Sci USA 21:1081, 1993
42. Chu THT, Dornburg R: Toward highly cell type specific gene transfer with retroviral vectors displaying single chain antibodies. J Virol 71:720, 1997
43. Cosset F-L, Russell SJ: Targeting retrovirus entry. Gene Ther 3:946, 1996
44. Schwarzenberger P, Spence SE, Gooya JM, Michiel D, Curiel DT, Ruscetti FW, Keller JR: Targeted gene transfer to human hematopoietic progenitor cell lines through the c-kit receptor. Blood 87:472, 1996
45. Peng K-W, Morling FJ, Cosset F-L, Murphy G, Russell SJ: A gene delivery system activatable by disease associated matrix metalloproteinases Hum Gene Ther 8:729, 1997
46. Morling FJ, Peng K-W, Cosset F-L, Russell SJ: Masking of retroviral envelope functions by oligomerising peptide adaptors. Virology 24:51, 1997
47. Modjtahedi H, Dean C: The receptor for EGF and its ligands: Expression, prognostic value and target for therapy in cancer. Int J Oncol 4:277, 1994
48. Gusterson B, Cowley G, Smith JA, Ozanne B: Cellular localisation of human epidermal growth factor receptor. Cell Biol Int 8:649, 1994
49. Podda S, Ward M, Himelstein A, Richardson C, de la Flor Weiss E, Smith L, Gottesman M, Pastan I, Bank A: Transfer and expression of the human multiple drug resistance gene into live mice. Proc Natl Acad Sci USA 89:9676, 1992
50. Ross AA, Cooper BW, Lazarus HM, Mackay W, Moss TJ, Ciobanu N, Tallman MS, Kennedy J, Davidson NE, Sweet D, Winter C, Akard L, Jansen J, Copelan E, Meagher RC, Herzig RH, Klumpp TR, Kahn DG, Warner NE: Detection and viability of tumour cells in peripheral blood stem cell collections from breast cancer patients using immunocytochemical and clonogenic assay techniques. Blood 82:2605, 1993
51. Brugger W, Bross KJ, Glatt M, Weber F, Mertlesmann R, Kanz L: Mobilisation of tumour cells and hematopoietic progenitors into the peripheral blood of patients with solid tumours. Blood 83:636, 1994
52. Bonini C, Ferrari G, Verzelltetti S, Servida P, Zappone E, Ruggieri L, Ponzoni M, Rossini S, Mavilio F, Traversari C, Bordignon C: HSV-TK gene transfer into donor lymphocytes for control of allogenic graft-versus-leukemia. Science 276:1719, 1997